S

Cassava Sciences
D

SAVA

2.36500
USD
-0.16
(-6.34%)
مغلق
حجم التداول
45,105
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
114,248,174
أصول ذات صلة
A
ACIU
0.02000
(0.82%)
2.46000 USD
A
AVXL
-0.635
(-4.98%)
12.125 USD
AZN
AZN
-1.055
(-1.43%)
72.640 USD
BIIB
BIIB
-1.010
(-0.76%)
131.630 USD
C
CRSP
-1.350
(-2.04%)
64.760 USD
F
FATE
-0.01000
(-0.80%)
1.23500 USD
IQV
IQV
-1.690
(-0.84%)
199.180 USD
S
SAGE
0.04000
(0.46%)
8.80500 USD
المزيد
الأخبار المقالات

العنوان: Cassava Sciences

القطاع: Healthcare
الصناعة: Biotechnology
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.